Insights

Sustainability Initiatives Bioton's recent partnership with BNP Paribas Leasing Solutions to install a 1.9 MW solar energy plant demonstrates a strong commitment to sustainability, presenting opportunities to offer renewable energy solutions or green financing services.

Market Expansion The company's recent expansion of export operations to Egypt, Hong Kong, and Tunisia indicates growth in international markets, opening possibilities for regional distributors, logistics providers, and regulatory consulting services.

Innovation & R&D Bioton's leadership in Polish biotech and collaboration with scientific institutes reveal a focus on innovative therapeutics and technological solutions, suggesting opportunities for advanced biotech equipment, R&D partnerships, or customized manufacturing services.

Employee Engagement The launch of initiatives like the BIOTON Benefit Cafeteria and efforts to build comprehensive solutions for diabetes treatment highlight a dedicated approach to employee well-being and customer-centricity, which could be leveraged to promote HR services or patient engagement technologies.

Industry Positioning As one of the top eight global producers of recombinant human insulin with significant revenues, Bioton presents a key opportunity for suppliers of high-tech manufacturing equipment, cGMP-compliant solutions, or quality control services tailored to large biotech firms.

BIOTON S.A. Tech Stack

BIOTON S.A. uses 8 technology products and services including Hotjar, C3.js, Microsoft 365, and more. Explore BIOTON S.A.'s tech stack below.

  • Hotjar
    Analytics
  • C3.js
    Charting
  • Microsoft 365
    Email
  • Google Fonts API
    Font Scripts
  • Slick
    Javascript Libraries
  • Lodash
    Javascript Libraries
  • Bootstrap
    UI Frameworks
  • AddToAny Share Buttons
    Web Platform Extensions

BIOTON S.A.'s Email Address Formats

BIOTON S.A. uses at least 2 format(s):
BIOTON S.A. Email FormatsExamplePercentage
FirstL@bioton.plJohnD@bioton.pl
61%
First.Last@bioton.plJohn.Doe@bioton.pl
21%
LastF@bioton.plDoeJ@bioton.pl
11%
Last@bioton.plDoe@bioton.pl
7%

Frequently Asked Questions

Where is BIOTON S.A.'s headquarters located?

Minus sign iconPlus sign icon
BIOTON S.A.'s main headquarters is located at Macierzysz, ul. Poznańska, 12 Ożarów Mazowiecki, Mazowieckie 05-850, PL. The company has employees across 3 continents, including EuropeAsiaNorth America.

What is BIOTON S.A.'s official website and social media links?

Minus sign iconPlus sign icon
BIOTON S.A.'s official website is bioton.com and has social profiles on LinkedInCrunchbase.

What is BIOTON S.A.'s SIC code NAICS code?

Minus sign iconPlus sign icon
BIOTON S.A.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BIOTON S.A. have currently?

Minus sign iconPlus sign icon
As of October 2025, BIOTON S.A. has approximately 265 employees across 3 continents, including EuropeAsiaNorth America. Key team members include Chief Operating Officer: B. L.Chief Operating Officer: B. M. K.Head Of Biolek Global Business Unit: M. K.. Explore BIOTON S.A.'s employee directory with LeadIQ.

What industry does BIOTON S.A. belong to?

Minus sign iconPlus sign icon
BIOTON S.A. operates in the Biotechnology Research industry.

What technology does BIOTON S.A. use?

Minus sign iconPlus sign icon
BIOTON S.A.'s tech stack includes HotjarC3.jsMicrosoft 365Google Fonts APISlickLodashBootstrapAddToAny Share Buttons.

What is BIOTON S.A.'s email format?

Minus sign iconPlus sign icon
BIOTON S.A.'s email format typically follows the pattern of FirstL@bioton.pl. Find more BIOTON S.A. email formats with LeadIQ.

When was BIOTON S.A. founded?

Minus sign iconPlus sign icon
BIOTON S.A. was founded in 1989.
BIOTON S.A.

BIOTON S.A.

Biotechnology ResearchPoland201-500 Employees

Bioton S.A. - European Biotech Company producing human insulin: API and finished forms in cartridges and vials. For more than 20 years, we have been providing people with diabetes with efficacious and safe medicines. Bioton S.A. is an unquestionable leader on the Polish market, and in the world’s top eight commercial manufacturers of recombinant human insulin. Bioton S.A. continuously invests in the development of Polish biotechnology. We were the first company in Poland which, in cooperation with one of Polish scientific institutes, managed to commercialize the results of the Biotech Transfer. We apply the most current therapeutic and technological solutions to alleviate diabetes treatment for patients. We strive to build comprehensive solutions for the prevention and treatment of diabetes. Bioton S.A. offers CMO/CDMO and QC services. Our activities are based on QbD in line with cGMP standards. Bioton S.A. supplies also a range of innovative gastroenterological FSMP (Foods for Special Medical Purposes).

Section iconCompany Overview

Headquarters
Macierzysz, ul. Poznańska, 12 Ożarów Mazowiecki, Mazowieckie 05-850, PL
Website
bioton.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1989
Employees
201-500

Section iconFunding & Financials

  • $1M$10M

    BIOTON S.A.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    BIOTON S.A.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.